Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients

Diabetes Care

Volumn 22, Issue 3, 1999, Pages 459-462

  Koivisto, Veikko A ^a   Tuominen, Juha A ^a   Ebeling, Pertti ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN DERIVATIVE; INSULIN LISPRO; INSULIN MIX25; ISOPHANE INSULIN; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG MIXTURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESPONSE; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION;

EID: 0033010327     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.3.459     Document Type: Article

References (17)

1. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR: [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analog of human insulin. Diabetes 43:396-402, 1994
2. Holcombe JH, Brunelle R, Zalani S, Deeb LC: Comparative study of insulin lispro and regular insulin in prepubertal children with type 1 diabetes (Abstract). Diabetes 47 (Suppl. 1):A96, 1998
3. Anderson JH Jr, Brunelle R, Koivisto VA, Pfützner A, Trautmann ME, Vignati L, DiMarchi R, and the Multicenter Insulin Lispro Study Group: Reduction of post-prandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin analog treatment. Diabetes 46:265-270, 1997
4. Anderson JH Jr, Brunelle R, Keohane P, Koivisto VA, Trautmann ME, Vignati L, DiMarchi R: Insulin analogue improves mealtime treatment of NIDDM patients. Arch Intern Med 157:1249-1255, 1997
5. Bastyr EJ III, Holcombe J, Anderson JH Jr. Clore JN: Mixing insulin lispro with ultralente insulin. Diabetes Care 20:1047-1048, 1997
6. Kesson CM, Bailie GR: Do diabetic patients inject accurate dose of insulin? (Letter). Diabetes Care 4:333, 1981
7. Bell DSH, Clements RS Jr. Perentesis G, Roddam R, Wagenknecht L: Dosage accuracy of self-mixed vs premixed insulin. Arch Intern-Med 151:2265-2269, 1991
8. Coscelli C, Calabrese G, Fedele D, Pisu E, Calderini C, Bistoni S, Lapolla A, Mauri MG, Rossi A, Zappella A: Use of premixed insulin among the elderly Reduction of errors in patient preparation of mixtures. Diabetes Care 15:1628-1630, 1992
9. Aronoff S, Goldberg R, Kumar D, Lichtenstein E, Schwartz S, Sosenko J: Use of premixed insulin regimen (Novolin 70/30) to replace self-mixed insulin regimens. Clin Ther 16:41-49, 1994
10. Dunbar JM, Madden PM, Gleeson DT, Fiad TM, McKenna TJ: Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients. Diabetes Care 17:874-878, 1994
11. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
12. Holloway DL, Santa PF, Compton JA, Bowsher RR: Humalog, a rapidly absorbed analog of human insulin, determined with Coat-A-Count insulin RIA. Clin Chem 41:1777-1778, 1995
13. Burge MR, McLeod J, Bowsher RR, Schade DS: Validity of Coat-A-Count insulin RIA kit for quantifying total and free humalog (Letter). Clin Chem 42:777, 1996
14. Heding LG: Radioimmunological determination of human C-peptide in serum. Diabetologia 11:541-548, 1975
15. Bell DSH, Cutter GR, Lauritano AA: Efficacy of a premixed semisynthetic human insulin regimen. Clin Ther 11:795-801, 1989
16. Roach P, Trautmann ME, Anderson JH, and the Mix25 Study Group: Improved post-prandial glycemia during treatment with a intermediate acting insulin mixture, Mix25 (Abstract). Diabetologia 41 (Suppl. 1):A244, 1998
17. Roach P, Trautmann M, Anderson J, and the LM Study Group: Lower incidence of nocturnal hypoglycemia during treatment with a novel protamine-based formulation of insulin lispro (Abstract). Diabetes 47 (Suppl. 1):A92, 1998